State-of-the-Art Hysterectomy for Malignancy — Are Some Women Shut Out?

Nationwide analysis suggests minimally invasive approaches are less commonly used in minority and low-income women.

Minimally invasive surgery (MIS; laparoscopic, robotic, or vaginal hysterectomy) for gynecologic malignancies is associated with less blood loss, shorter hospital stay, and faster recovery than abdominal hysterectomy. To explore whether this approach is equitably available to all U.S. women, investigators conducted a cross-sectional analysis of all-payer database that included 20% of U.S. hospital discharges. Of an estimated 28,160 hysterectomies performed in 2012 for endometrial cancer, half were abdominal and half were performed via MIS (38% robotic, 11% laparoscopic, and 1% vaginal).

Compared with white women undergoing hysterectomy for endometrial cancer, black and Native American women were less likely to have MIS (adjusted odds ratios,…

Reviewing Author

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

State-of-the-Art Hysterectomy for Malignancy — Are Some Women Shut Out?

Topics

Reviewing Author